In this discussion we will review the mechanism of Ivermectin against mutating SARS-COV-2.
These mechanisms are potential mechanisms observed in-silico, in-vitro, or in-vivo.
1. Ivermectin continues to bind with the Spike protein of the SARS-COV-2.
2. How ivermectin disrupts the viral replication by disrupting RdRp and 3-CTLP?
3. How ivermectin continues to help the cell produce interferons, regardless of the varaint?
4. How ivermectin continues to work on the nuclear factor kapp beta pathway?
Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.